Healthcare

https://techpapersworld.com/wp-content/uploads/2024/12/SINOVAC-Initiated-a-Phase-III-Clinical-1280x720.jpg

HealthcareSINOVAC Initiated a Phase III Clinical Trial on Bivalent Vaccine Against Hand Foot and Mouth Disease (HFMD)

Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today kicked off the enrollment for a Phase III clinical trial on a vaccine candidate to prevent HFMD caused by both Enterovirus 71 (EV71) and Coxsackievirus 16 (CA16). Notably, no multivalent vaccines against HFMD have yet been approved for marketing worldwide. The Phase III clinical trial is designed to be a multicenter, randomized, double-blind, controlled trial to evaluate...

by PRNewswire

https://techpapersworld.com/wp-content/uploads/2024/12/Salipro-Biotech-Expands-Global-1280x720.jpg

HealthcareSalipro Biotech Expands Global Intellectual Property Portfolio with Granted Patents in Australia and Singapore

Salipro Biotech AB, a Swedish biotechnology company focused on advancing drug discovery for challenging drug targets, today announced the issuance of granted patents in both Singapore and Australia for its Salipro® platform technology, a novel and proprietary method for directly isolating and purifying native membrane proteins, which are important targets for many therapeutic drugs. The Salipro® platform enables entirely novel drug discovery programs, including antibody discovery, small molecule drug screening and structure-based drug design. The patents, entitled “Production of...

by PRNewswire

https://techpapersworld.com/wp-content/uploads/2024/12/AC-Health-makes-critical-HIV-1280x720.jpg

HealthcareAC Health makes critical HIV care more accessible to Filipinos with USAID support

Ayala Healthcare Holdings, Inc. (AC Health), in partnership with the U.S. Agency for International Development (USAID), is leading the private sector’s efforts to fight the HIV epidemic in the Philippines by improving access to stigma-free care and lifesaving services. The partnership was sealed in time for World AIDS Day, whose theme “Collective Action: Sustain and Accelerate HIV Progress,” underscores the importance of collaboration to overcome this health challenge. [Left to Right] Andrea Halverson, USAID Health Office Director;...

by PRNewswire

https://techpapersworld.com/wp-content/uploads/2024/12/Countertop-Workers-Exposed-1280x720.jpg

HealthcareCountertop Workers Exposed to Serious Lung Disease

Durable and attractive, engineered stone countertops are a popular feature in modern American kitchens, but the workers who build them are risking their health. A growing number of these countertop workers are developing silicosis, a serious and long-term lung disease, according to a study being presented today at the annual meeting of the Radiological Society of North America (RSNA). “This is a new and emerging epidemic, and we must increase awareness of this disease process so we can avoid...

by business wire

https://techpapersworld.com/wp-content/uploads/2024/12/Revelation-Biosciences-Inc.-Announces-1280x720.jpg

HealthcareRevelation Biosciences Inc. Announces FDA Acceptance of Gemini IND

Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the treatment of disease, announced today that the United States Food and Drug Administration (FDA) has accepted its investigational new drug (IND) application for Gemini. This game changing milestone allows the Company to initiate its US based Phase 1b clinical study to evaluate the potential of Gemini as a preconditioning treatment in...

by business wire

https://techpapersworld.com/wp-content/uploads/2024/12/Neo-Medicals-Spine-Care-Platform-Fully-1280x720.jpg

HealthcareNeo Medical’s Spine Care Platform Fully Approved Under EU Medical Device Regulation Directive

Neo Medical SA (Neo), a Swiss technology company specializing in spine surgery, today announced the approval of its entire product portfolio under the European Union’s (EU) Medical Device Regulation (MDR) EU 2017/745, confirming compliance with the world’s highest quality control standards for medical devices. “Full MDR certification is an important milestone in Neo’s history. From the outset, we committed to a program of long-term clinical evaluation. MDR certification acknowledges the strength and validity of our...

by PRNewswire

https://techpapersworld.com/wp-content/uploads/2024/11/BrainCo-Intelligent-Prosthetic-Bionic--1280x720.jpg

HealthcareBrainCo Intelligent Prosthetic Bionic Hand Wins the 2024 CATON FAIR DESIGN AWARD

On October 24th, the award ceremony for the 2024 CATON FAIR DESIGN AWARD was held in Guangzhou. In this selection, BrainCo Intelligent Prosthetic Bionic Hand was honored with the highest accolade of the event, the Best of the Best Award, while another product, the BrainCo Intelligent Prosthetic Bionic Knee M3 received the Gold Award. The China Import and Export Fair is an important showcase window for the Chinese design field, and its CATON FAIR DESIGN AWARD is also known...

by business wire

https://techpapersworld.com/wp-content/uploads/2024/11/DEKAS-EXCELLENCE-IN-LASER-TECHNOLOGY-1280x720.jpg

HealthcareDEKA’S EXCELLENCE IN LASER TECHNOLOGY CONTINUES TO EXTEND ACROSS FRANCE AND NORTH AFRICA

With its focus on innovation and customer satisfaction, DEKA, which is part of the multinational El.En. group, listed on the Euronext Star segment of the Italian Stock Exchange, continues to transform the laser application landscape in several sectors, including aesthetic medicine, surgery and the restoration of works of art. Since 1981, El.En. Group has been a global leader in optoelectronics, photonics and laser engineering capabilities. The group founded its French subsidiary – DEKA Sarl –...

by business wire

https://techpapersworld.com/wp-content/uploads/2024/11/QIAGEN-Strengthens-QIAstat-Dx-With-1280x720.jpg

HealthcareQIAGEN Strengthens QIAstat-Dx With New Barcelona Site to Drive Growth in Infectious Diseases and Precision Medicine Testing

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced plans to move its QIAstat-Dx operations within the Barcelona area to a new site in Esplugues de Llobregat as part of a multi-year investment to strengthen this business. “Risk Factors in our most recent Annual Report on Form 20-F. For further information, please refer to the discussions in reports that QIAGEN has filed with, or furnished to, the U.S. Securities and Exchange Commission. ” Set to...

by business wire

https://techpapersworld.com/wp-content/uploads/2024/11/Sudden-Hearing-Loss-Study-Reaches-Milestone-1280x720.jpg

HealthcareSudden Hearing Loss Study Reaches Milestone: AudioCure Pharma Enrolls More Than Half of the Patients in AC102 Study

Berlin-based start-up AudioCure Pharma has enrolled more than 50% of the planned patients in its ongoing Phase 2 clinical trial. The aim of the study is to test the efficacy of the new compound AC102 for the treatment of sudden hearing loss. As sudden hearing loss is usually treated with non-specific corticoids that are not approved for this indication or for which there is no clear evidence of efficacy, there is an urgent need for...

Newer Posts

Older Posts